Kadry Elsaeed
Cairo, C, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Diabetic patients with chronic hepatitis C virus response compared to non diabetics when treated with directly acting antiviral therapy.
Journal: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology
Published: March 31, 2022
Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease.
Journal: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology
Published: October 01, 2020
High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study.
Journal: Expert review of gastroenterology & hepatology
Published: June 08, 2019
High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naïve and experienced chronic hepatitis C genotype 4: Real world results.
Journal: Journal of medical virology
Published: March 03, 2019
Real-Life Efficacy of 5 Different Antiviral Regimens for Treatment of Chronic Hepatitis C With Normal Liver Enzymes.
Journal: American journal of therapeutics
Published: August 21, 2018
An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.
Journal: Expert review of gastroenterology & hepatology
Published: May 15, 2018
Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: January 23, 2018
High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct acting antiviral therapy.
Journal: Hepatology international
Published: October 12, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026